The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
The peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is a member of the nuclear receptor superfamily of ligand-dependent transcription factors that is predominantly expressed in adipose tissue, adrenal gland and spleen. PPAR-gamma has been demonstrated to regulate adipocyte differentiation and glucose homeostasis in response to several structurally distinct compounds, including thiazolidinediones and fibrates. Naturally occurring compounds such as fatty acids and the prostaglandin D2 metabolite 15-deoxy-delta prostaglandin J2 (15d-PGJ2) bind to PPAR-gamma and stimulate transcription of target genes. Prostaglandin D2 metabolites have not yet been identified in adipose tissue, but are major products of arachidonic-acid metabolism in macrophages, raising the possibility that they might serve as endogenous PPAR-gamma ligands in this cell type. Here we show that PPAR-gamma is markedly upregulated in activated macrophages and inhibits the expression of the inducible nitric oxide synthase, gelatinase B and scavenger receptor A genes in response to 15d-PGJ2 and synthetic PPAR-gamma ligands. PPAR-gamma inhibits gene expression in part by antagonizing the activities of the transcription factors AP-1, STAT and NF-kappaB. These observations suggest that PPAR-gamma and locally produced prostaglandin D2 metabolites are involved in the regulation of inflammatory responses, and raise the possibility that synthetic PPAR-gamma ligands may be of therapeutic value in human diseases such as atherosclerosis and rheumatoid arthritis in which activated macrophages exert pathogenic effects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In microglia and macrophages, PPAR␥ activation inhibits proinflammatory gene expression (Jiang et al., 1998;Ricote et al., 1998).”
From PPARγ/RXRα-Induced and CD36-Mediated Microglial Amyloid-β Phagocytosis Results in Cognitive Improvement in Amyloid Precursor Protein/Presenilin 1 Mice (2012) · cites this paper as Ricote et al., 1998
In the citing paper
“Moreover, inhibiting nuclear factor B (NFB) decreases expression of inflammatory cytokines such as interleukin (IL)-1, tumor necrosis factor ␣ (TNF␣) or IL-6 (12).”
From MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor γ (PPARγ) mRNA Destabilization (2010) · cites this paper as [12]
In the citing paper
“PPAR␥ is well established for its anti-inflammatory effects in attenuating the production of pro-inflammatory mediators (12).”
From MicroRNA-27b Contributes to Lipopolysaccharide-mediated Peroxisome Proliferator-activated Receptor γ (PPARγ) mRNA Destabilization (2010) · cites this paper as [12]
In the citing paper
“Next to its role in HSCs, PPAR-γ is primarily expressed in macrophages and is capable to inhibit AP-1, STAT1 and NF-κB, therefore decreasing the inflammatory response.[136]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [136]
In the citing paper
“Next to its role in HSCs, PPAR-γ is primarily expressed in macrophages and is capable to inhibit AP-1, STAT1 and NF-κB, therefore decreasing the inflammatory response.[136]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [136]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., & Tannenbaum, S. R. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90118-x · Cited by 12,077
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Self-citationStimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Self-citationKliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
The matrix‐degrading metalloproteinases
Matrisian, L. M. (1992) · BioEssays · doi:10.1002/bies.950140705 · Cited by 1,364
Krey, G. D., Braissant, O., L’Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., & Wahli, W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.779 · Cited by 1,221
Cited by
Items 801–900 of 1,039
Krogsdam, A., Nielsen, C. A. F., Neve, S., Holst, D., Helledie, T., Thomsen, B., Bendixen, C., Mandrup, S., & Kristiansen, K. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3630157 · Cited by 104
Zhao, Y., Patzer, A., Gohlke, P., Herdegen, T., & Culman, J. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04200.x · Cited by 109
Anticancer properties of oxidation products of docosahexaenoic acid
Siddiqui, R. A., Harvey, K. A., & Stillwell, W. H. (2008) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2008.02.009 · Cited by 116
Renga, B., Mencarelli, A., Cipriani, S., D'Amore, C., Carino, A., Bruno, A., Francisci, D., Zampella, A., Distrutti, E., & Fiorucci, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054472 · Cited by 103
Aiello, A., Pandini, G., Frasca, F., Conte, E., Murabito, A., Sacco, A., Genua, M., Vigneri, R., & Belfiore, A. (2006) · Endocrinology · doi:10.1210/en.2005-1610 · Cited by 105
The DNA methylation drift of the atherosclerotic aorta increases with lesion progression
Valencia-Morales, M. D. P., Zaina, S., Heyn, H., Carmona, F. J., Varol, N., Sayols, S., Condom, E., Ramírez-Ruz, J., Gomez, A., Moran, S., et al. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0085-1 · Cited by 104
Modulators of inflammation in Bronchopulmonary Dysplasia
Savani, R. C. (2018) · Seminars in Perinatology · doi:10.1053/j.semperi.2018.09.009 · Cited by 105
Role of Peroxisome Proliferator‐Activated Receptors in Inflammation Control
Youssef, J., & Badr, M. (2004) · BioMed Research International · doi:10.1155/s1110724304308065 · Cited by 103
Chinetti, G., Fruchart, J.-C., & Staels, B. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200310000-00006 · Cited by 103
Coste, A., Dubourdeau, M., Linas, M.-D., Cassaing, S., Lepert, J., Balard, P., Chalmeton, S., Bernad, J., Orfila, C., Séguéla, J. P., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00229-2 · Cited by 115
Epithelial cell PPARγ contributes to normal lung maturation
Simon, D. M., Arıkan, M., Srisuma, S., Bhattacharya, S., Tsai, L. W., Ingenito, E. P., Gonzalez, F. J., Shapiro, S. D., & Mariani, T. J. (2006) · The FASEB Journal · doi:10.1096/fj.05-5410fje · Cited by 115
Cannabidiol in Inflammatory Bowel Diseases: A Brief Overview
Esposito, G., Filippis, D. D., Cirillo, C., Iuvone, T., Capoccia, E., Scuderi, C., Steardo, A., Cuomo, R., & Steardo, L. (2013) · Phytotherapy Research · doi:10.1002/ptr.4781 · Cited by 101
Ito, H., Nakano, A., Kinoshita, M., & Matsumori, A. (2003) · Laboratory Investigation · doi:10.1097/01.lab.0000106724.29121.da · Cited by 104
Xie, S., Lee, Y.-F., Kim, E., Chen, L.-M., Ni, J., Fang, L., Liu, S., Lin, S.-J., Abe, J., Berk, B. C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905724106 · Cited by 118
Molecular determinants for the polarization of macrophage and osteoclast
Yang, D., & Wan, Y. (2019) · Seminars in Immunopathology · doi:10.1007/s00281-019-00754-3 · Cited by 107
Nuclear receptor signaling in macrophages
Valledor, A. F., & Ricote, M. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.10.016 · Cited by 117
Self-citationChao, T., Leu, H., Huang, C., Chen, J., Chan, W., Lin, S., & Chen, S.-A. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.08.081 · Cited by 107
Jaudszus, A., Krokowski, M., Möckel, P., Darcan, Y., Avagyan, A., Matricardi, P. M., Jahreis, G., & Hamelmann, E. H. (2008) · Journal of Nutrition · doi:10.1093/jn/138.7.1336 · Cited by 114
Maternal PPARγ protects nursing neonates by suppressing the production of inflammatory milk
Wan, Y., Saghatelian, A., Chong, L.-W., Zhang, C.-L., Cravatt, B. F., & Evans, R. M. (2007) · Genes & Development · doi:10.1101/gad.1567207 · Cited by 104
The Role of PPAR-γ in Allergic Disease
Stark, J. M., Coquet, J. M., & Tibbitt, C. A. (2021) · Current Allergy and Asthma Reports · doi:10.1007/s11882-021-01022-x · Cited by 96
Youssef, A., White, M. S., Villanueva, E. B., El‐Ashmawy, I. M., & Klegeris, A. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.01.021 · Cited by 110
Boelsterli, U. A., & Bedoucha, M. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00817-6 · Cited by 111
Sykes, L., MacIntyre, D. A., Yap, X. J., Ponnampalam, S., Teoh, T. G., & Bennett, P. R. (2012) · Mediators of Inflammation · doi:10.1155/2012/416739 · Cited by 114
Klotz, L., Schmidt, M., Giese, T., Sastre, M., Knolle, P., Klockgether, T., & Heneka, M. T. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.4948 · Cited by 102
RAR/RXR and PPAR/RXR signaling in neurological and psychiatric diseases
van Neerven, S., Kampmann, E., & Mey, J. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.04.006 · Cited by 108
Kumar, A. P., Piedrafita, F. J., & Reynolds, W. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311625200 · Cited by 111
Zhao, M., Liu, Y., Wang, X., New, L., Han, J., & Brunk, U. T. (2002) · APMIS · doi:10.1034/j.1600-0463.2002.100604.x · Cited by 101
Reddy, R. C., Narala, V. R., Keshamouni, V. G., Milam, J. E., Newstead, M. W., & Standiford, T. J. (2008) · Blood · doi:10.1182/blood-2007-12-128967 · Cited by 99
Bright, J. J., Natarajan, C., Muthian, G., Barak, Y., & Evans, R. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5743 · Cited by 103
Ma, L., Xie, C., Ma, Y., Liu, J., Xiang, M., Ye, X., Zheng, H., Chen, Z., Xu, Q., Chen, T., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm1011534 · Cited by 102
Ogawa, S., Urano, T., Hosoi, T., Miyao, M., Hoshino, S., Fujita, M., Shiraki, M., Orimo, H., Ouchi, Y., & Inoue, S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0896 · Cited by 107
Saremi, A., Schwenke, D. C., Buchanan, T. A., Hodis, H. N., Mack, W. J., Banerji, M., Bray, G. A., Clement, S. C., Henry, R. R., Kitabchi, A. E., et al. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300346 · Cited by 101
Bassaganya-Riera, J., Misyak, S., Guri, A. J., & Hontecillas, R. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.04.003 · Cited by 100
Chang, P.-C., Chen, T.-H., Chang, C.-J., Hou, C.-C., Chan, P., & Lee, H.-M. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00602.x · Cited by 104
Combs, C. K., Bates, P., Karlo, J. C., & Landreth, G. E. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00052-3 · Cited by 108
PPARδ Functions as a Prostacyclin Receptor in Blastocyst Implantation
Lim, H. J., & Dey, S. K. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00243-5 · Cited by 108
Kobayashi, T., Notoya, K., Naito, T., Unno, S., Nakamura, A., Martel‐Pelletier, J., & Pelletier, J. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20792 · Cited by 102
Wang, K.-T., Chen, L.-G., Wu, C., Chang, C., & Wang, C. (2010) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.62.03.0014 · Cited by 101
Rosiglitazone Reduces the Development and Rupture of Experimental Aortic Aneurysms
Jones, A., Deb, R., Torsney, E., Howe, F. A., Dunkley, M., Gnaneswaran, Y., Gaze, D. C., Nasr, H. H., Loftus, I. M., Thompson, M. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.852467 · Cited by 108
PPARγand Its Role in Cardiovascular Diseases
Chandra, M., Miriyala, S., & Panchatcharam, M. (2017) · PPAR Research · doi:10.1155/2017/6404638 · Cited by 104
Induction of cyclooxygenase-2 by mechanical stress through a nitric oxide-regulated pathway
Fermor, B., Weinberg, J. B., Pisetsky, D. S., Misukonis, M. A., Fink, C., & Guilak, F. (2002) · Osteoarthritis and Cartilage · doi:10.1053/joca.2002.0832 · Cited by 110
Jain, S. R., Pulikuri, S., Zhu, Y., Qi, C., Kanwar, Y. S., Yeldandi, A. V., Rao, M. S., & Reddy, J. K. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65577-0 · Cited by 110
Atherosclerotic plaque rupture: emerging insights and opportunities
Plutzky, J. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00352-5 · Cited by 112
Ray, B., B. Chauhan, N., & K. Lahiri, D. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711796504664 · Cited by 100
Spinelli, S. L., Pollock, S. J., Murant, T. I., O'Brien, J. J., Blumberg, N., Francis, C. W., Taubman, M. B., Ray, D. M., & Phipps, R. P. (2007) · Thrombosis and Haemostasis · doi:10.1160/th07-05-0328 · Cited by 100
Regulation of Th17 Differentiation by Epidermal Fatty Acid-Binding Protein
Li, B., Reynolds, J. M., Stout, R. D., Bernlohr, D. A., & Suttles, J. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804192 · Cited by 101
Yu, X., Shao, X., Sun, H. B., Li, Y., Yang, J., Deng, Y., & Huang, Y. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.047 · Cited by 105
Hontecillas, R., Horne, W. T., Climent, M., Guri, A. J., Evans, C., Zhang, Y.-F., Sobral, B., & Bassaganya-Riera, J. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.75 · Cited by 100
Activation of transcription factors and gene expression by oxidized low-density lipoprotein
Mazière, C., & Mazière, J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.10.024 · Cited by 109
Hsi, L. C., Wilson, L. C., Nixon, J. B., & Eling, T. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100280200 · Cited by 100
Lytle, C., Tod, T. J., Vo, K. T., Lee, J. W., Atkinson, R. D., & Straus, D. S. (2005) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000160805.46235.eb · Cited by 99
Hwang, J., Kleinhenz, D. J., Rupnow, H. L., Campbell, A. G., Thulé, P. M., Sutliff, R. L., & Hart, C. M. (2007) · Vascular Pharmacology · doi:10.1016/j.vph.2007.01.007 · Cited by 104
Xu, J., Chavis, J. A., Racke, M. K., & Drew, P. D. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.04.019 · Cited by 107
The Metabolic Syndrome and Stroke: Potential Treatment Approaches
Arenillas, J. F., Moro, M. Á., & Dávalos, A. (2007) · Stroke · doi:10.1161/strokeaha.106.480004 · Cited by 111
Álvarez-Maqueda, M., Bekay, R. E., Álba, G., Monteseirín, J., Chacón, P., Vega, A. P., Martín‐Nieto, J., Bedoya, F. J., Pintado, E., & Sobrino, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400492200 · Cited by 105
Wu, J., Lin, T., & Wu, K. K. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21730 · Cited by 106
Lautamäki, R., Airaksinen, K. E. J., Seppänen, M., Toikka, J., Luotolahti, M., Ball, E., Borra, R., Härkönen, R., Iozzo, P., Stewart, M., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2787 · Cited by 98
Mencarelli, A., Distrutti, E., Renga, B., D'Amore, C., Cipriani, S., Palladino, G., Donini, A., Ricci, P., & Fiorucci, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022978 · Cited by 97
Drew, P. D., Xu, J., Storer, P. D., Chavis, J. A., & Racke, M. K. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.04.003 · Cited by 104
Bosma, K. J., Taneja, R., & Lewis, J. F. (2010) · Drugs · doi:10.2165/10898570-000000000-00000 · Cited by 107
Cuzzocrea, S., Pisano, B., Dugo, L., Ianaro, A., Patel, N. S. A., Paola, R. D., Genovese, T., Chatterjee, P. K., Rosa, M. D., Caputi, A. P., et al. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705419 · Cited by 97
Cyclopentenone Isoprostanes Inhibit the Inflammatory Response in Macrophages
Musiek, E. S., Gao, L., Milne, G. L., Han, W., Everhart, M. B., Wang, D., Backlund, M. G., DuBois, R. N., Zanoni, G., Vidari, G., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504785200 · Cited by 96
Wang, T., Wang, Z., Yang, P., Xia, L., Zhou, M., Wang, S., Du, J., & Zhang, J. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.9 · Cited by 100
Nanbu-Wakao, R., Fujitani, Y., Masuho, Y., Muramatu, M.-A., & Wakao, H. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.2.0420 · Cited by 108
Mechanisms by which Thiazolidinediones Enhance Insulin Action
Reginato, M. J., & Lazar, M. A. (1999) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(98)00110-6 · Cited by 93
WY14,643, a PPARα Ligand, Has Profound Effects on Immune Responses In Vivo
Cunard, R., DiCampli, D., Archer, D. C., Stevenson, J. L., Ricote, M., Glass, C. K., & Kelly, C. J. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6806 · Cited by 96
Self-citationCorti, R., Osende, J. I., Fallon, J. T., Fuster, V., Mizsei, G., Jneid, H. M., Wright, S. D., Chaplin, W. F., & Badimón, J. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.08.048 · Cited by 100
Brand, S., Moller, M., & Harvey, B. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150307004545 · Cited by 95
Nuclear Receptors in Bone Physiology and Diseases
Imai, Y., Youn, M.-Y., Inoue, K., Takada, I., Kouzmenko, A., & Kato, S. (2013) · Physiological Reviews · doi:10.1152/physrev.00008.2012 · Cited by 88
Gut microbiome, metabolome, and allergic diseases
Hirata, S.-I., & Kunisawa, J. (2017) · Allergology International · doi:10.1016/j.alit.2017.06.008 · Cited by 93
Abdel-Moneim, A., El-Twab, S. M. A., Yousef, A. I., Reheim, E. S. A., & Ashour, M. B. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.06.096 · Cited by 92
Sakamoto, H., Aikawa, M., Hill, C. C., Weiss, D., Taylor, W. R., Libby, P., & Lee, R. T. (2001) · Circulation · doi:10.1161/hc2701.091070 · Cited by 93
Cuzzocrea, S., Ianaro, A., Wayman, N. S., Mazzon, E., Pisano, B., Dugo, L., Serraino, I., Paola, R. D., Chatterjee, P. K., Rosa, M. D., et al. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705077 · Cited by 99
Yu, J. H., Kim, K. H., & Kim, H. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.10.007 · Cited by 101
Multifarious molecular signaling cascades of cardiac hypertrophy: Can the muddy waters be cleared?☆
Balakumar, P., & Jagadeesh, G. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.07.003 · Cited by 102
Eto, H., Ishimine, H., Kinoshita, K., Watanabe-Susaki, K., D, H. K. M., Doi, K., Kuno, S., Kurisaki, A., & Yoshimura, K. (2012) · Stem Cells and Development · doi:10.1089/scd.2012.0442 · Cited by 98
Majdalawieh, A. F., Zhang, L., Fuki, I. V., Rader, D. J., & Ro, J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508139103 · Cited by 107
Davies, S. S., & Guo, L. (2014) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2014.03.002 · Cited by 98
Peroxisome proliferator-activated receptor agonists, hyperlipidaemia, and atherosclerosis
Vosper, H., Khoudoli, G. A., Graham, T. L., & Palmer, C. N. A. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00232-2 · Cited by 104
Rohn, T. T., Wong, S. M., Cotman, C. W., & Cribbs, D. H. (2001) · Neuroreport · doi:10.1097/00001756-200103260-00043 · Cited by 103
Ebeling, P. R., Teppo, A.-M., Koistinen, H. A., Viikari, J. S. A., R�nnemaa, T., Niss�n, M., Bergkulla, S., Salmela, P. I., Saltevo, J. T., & Koivisto, V. A. (1999) · Diabetologia · doi:10.1007/s001250051315 · Cited by 102
PPARs and Mitochondrial Metabolism: From NAFLD to HCC
Mello, T., Materozzi, M., & Galli, A. (2016) · PPAR Research · doi:10.1155/2016/7403230 · Cited by 102
A gut feeling of the PXR, PPAR and NF‐κB connection
Wahli, W. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01951.x · Cited by 94
Wu, L., Yan, C., Czader, M., Foreman, O., Blum, J. S., Kapur, R., & Du, H. (2012) · Blood · doi:10.1182/blood-2011-06-363093 · Cited by 93
Majdalawieh, A., & Ro, H.-S. (2010) · Nuclear Receptor Signaling · doi:10.1621/nrs.08004 · Cited by 90
Positioning prostanoids of the D and J series in the immunopathogenic scheme
Herlong, J. L., & Scott, T. R. (2005) · Immunology Letters · doi:10.1016/j.imlet.2005.10.004 · Cited by 100
Song, Z., Revelo, X. S., Shao, W., Tian, L., Zeng, K., Lei, H., Sun, H., Woo, M., Winer, D. A., & Jin, T. (2018) · Obesity · doi:10.1002/oby.22110 · Cited by 102
Molecular targets of non-steroidal anti-inflammatory drugs in neurodegenerative diseases
Lleo, A., Galea, E., & Sastre, M. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6516-1 · Cited by 93
A systematic review on the role of eicosanoid pathways in rheumatoid arthritis
Hoxha, M. (2017) · Advances in Medical Sciences · doi:10.1016/j.advms.2017.06.004 · Cited by 99
Alam, M. A., & Rahman, M. M. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-13-60 · Cited by 91
NICHOLSON, A. C. (2004) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2003.09.004 · Cited by 107
Kang, M., Hirai, S., Goto, T., Kuroyanagi, K., Lee, J., Uemura, T., Ezaki, Y., Takahashi, N., & Kawada, T. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.02.002 · Cited by 101
Recent findings concerning thiazolidinediones in the treatment of diabetes
Boden, G., & Zhang, M. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.3.243 · Cited by 92
Meirhaeghe, A., Fajas, L., Gouilleux, F., Cottel, D., Helbecque, N., Auwerx, J. H., & Amouyel, P. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000051382.28752.fe · Cited by 101
Lysosomal acid lipase deficiency causes respiratory inflammation and destruction in the lung
Lian, X., Yan, C., Li, Y., Xu, Y. J., & Du, H. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00335.2003 · Cited by 95
Boyault, S., Simonin, M.-A., Bianchi, A., Compe, E., Liagre, B., Mainard, D., Bécuwe, P., Dauça, M., Netter, P., Terlain, B., et al. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02614-x · Cited by 94
Sugawara, A., Uruno, A., Kudo, M., Ikeda, Y., Sato, K., Taniyama, Y., Ito, S., & Takeuchi, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104560200 · Cited by 102
Aizawa, Y., Kawabe, J.-I., Hasebe, N., Takehara, N., & Kikuchi, K. (2001) · Circulation · doi:10.1161/hc3001.092040 · Cited by 96
Cuzzocrea, S., Mazzon, E., Dugo, L., Patel, N. S. A., Serraino, I., Paola, R. D., Genovese, T., Britti, D., Maio, M. D., Caputi, A. P., et al. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11351 · Cited by 101
Fam, S. S., Murphey, L. J., Terry, E. S., Zackert, W. E., Chen, Y., Gao, L., Pandalai, S., Milne, G. L., Roberts, L. J., Porter, N. A., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205638200 · Cited by 93
Metadata
- Authors
- Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K.
- Affiliations
- United States Department of Veterans Affairs (US)
- Veterans Health Administration (US)
- University of California San Diego (US)
- Corresponding author
- Glass, Christopher K.
- Venue
- Nature
- Published
- 1998-01
- Volume
- 391
- Issue
- 6662
- Pages
- 79-82
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1633340712
- Cited by
- 3,525
- References
- 27
- Citations by year
- 2026: 30 · 2025: 41 · 2024: 34 · 2023: 44 · 2022: 59 · 2021: 84 · 2020: 73 · 2019: 65 · 2018: 89 · 2017: 82 · 2016: 86 · 2015: 95 · 2014: 113 · 2013: 106 · 2012: 137
- FWCI
- 53.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- PPARγ, macrophage activation, prostaglandin D2 metabolites, inducible nitric oxide synthase, MMP-9, scavenger receptor A, AP-1, STAT, NF-κB, transcriptional regulation, inflammation, atherosclerosis, rheumatoid arthritis, PPARγ ligands
- MeSH terms
- Bone Marrow Cells, Gene Expression Regulation, HeLa Cells, Humans, Macrophage Activation, Macrophages, Promoter Regions, Genetic, Transcription Factors, Tumor Cells, Cultured, Prostaglandin D2, Collagenases, Macrophages, Peritoneal, Receptors, Cytoplasmic and Nuclear, Inflammation Mediators, Nitric Oxide Synthase, Matrix Metalloproteinase 9
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.